Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
01 Février 2024 - 10:05PM
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision
medicine company transforming the drug discovery process by
combining leading-edge computational and experimental technologies,
today announced that management will participate in a fireside chat
at the Guggenheim Healthcare Talks 6th Annual Biotechnology
Conference on Thursday, February 8, 2024 at 10:30 a.m. ET.
The presentation will be webcast live and may be accessed
through Relay Therapeutics’ website under Events in the News &
Events section through the following link:
https://ir.relaytx.com/news-events/events-presentations. An
archived replay of the webcast will be available for up to 30 days
following the event.
About Relay Therapeutics
Relay Therapeutics is a clinical-stage precision medicine
company transforming the drug discovery process by combining
leading-edge computational and experimental technologies with the
goal of bringing life-changing therapies to patients. As the first
of a new breed of biotech created at the intersection of
complementary techniques and technologies, Relay Therapeutics aims
to push the boundaries of what’s possible in drug discovery. Its
Dynamo™ platform integrates an array of leading-edge computational
and experimental approaches designed to drug protein targets that
have previously been intractable or inadequately addressed. Relay
Therapeutics’ initial focus is on enhancing small molecule
therapeutic discovery in targeted oncology and genetic disease
indications. For more information, please visit www.relaytx.com or
follow us on Twitter.
Contact:Megan Goulart617-545-5526
mgoulart@relaytx.com
Media:Dan
Budwick1AB973-271-6085dan@1abmedia.com
Relay Therapeutics (NASDAQ:RLAY)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Relay Therapeutics (NASDAQ:RLAY)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024